436 related articles for article (PubMed ID: 22056419)
1. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
Feng X; Peng Y; Liu M; Cui L
Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis.
Feng XH; Yuan W; Peng Y; Liu MS; Cui LY
Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
4. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
[TBL] [Abstract][Full Text] [Related]
6. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
7. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Kipiani K; Petri S; Chen J; Calingasan NY; Beal MF
Neurodegener Dis; 2005; 2(5):246-54. PubMed ID: 16909005
[TBL] [Abstract][Full Text] [Related]
8. Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
Fontanilla CV; Wei X; Zhao L; Johnstone B; Pascuzzi RM; Farlow MR; Du Y
Neuroscience; 2012 Mar; 205():185-93. PubMed ID: 22206942
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
[TBL] [Abstract][Full Text] [Related]
11. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
[TBL] [Abstract][Full Text] [Related]
12. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
Yoo YE; Ko CP
Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
14. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y
Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020
[TBL] [Abstract][Full Text] [Related]
15. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of Withania somnifera extract in SOD1
Dutta K; Patel P; Julien JP
Exp Neurol; 2018 Nov; 309():193-204. PubMed ID: 30134145
[TBL] [Abstract][Full Text] [Related]
18. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
Shibata N; Yamamoto T; Hiroi A; Omi Y; Kato Y; Kobayashi M
Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
[TBL] [Abstract][Full Text] [Related]
19. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G
PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798
[TBL] [Abstract][Full Text] [Related]
20. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.
Trias E; Ibarburu S; Barreto-Núñez R; Babdor J; Maciel TT; Guillo M; Gros L; Dubreuil P; Díaz-Amarilla P; Cassina P; Martínez-Palma L; Moura IC; Beckman JS; Hermine O; Barbeito L
J Neuroinflammation; 2016 Jul; 13(1):177. PubMed ID: 27400786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
